Skip to content

Clinical trials

Phase 3 Liver Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 3 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20071
20083
20093
20102
20122
20131
20141
20153
20182
20191
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting5
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Bristol-Myers Squibb3
Memorial Sloan Kettering Cancer Center3
Bayer2
Bracco Diagnostics, Inc2
Imunon2
Abbott1
Alliance for Clinical Trials in Oncology1
Can-Fite BioPharma1
Children's Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms27
Carcinoma, Hepatocellular15
Neoplasms5
Pancreatic Neoplasms3
Adenocarcinoma2
Agnosia2
Bile Duct Neoplasms2
Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Digestive System Diseases2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.